Literature DB >> 2504141

Myocardial infarction in rats: effects of metabolic and pharmacologic interventions.

H G Zimmer1, P A Martius, G Marschner.   

Abstract

Myocardial infarction was induced in rats by ligation of the descending branch of the left coronary artery. The time course of changes in heart function was recorded within the first nine days. There was a progressive decline in LVSP, in LV dP/dtmax and in the pressure-rate-product. LVEDP was elevated. Cardiac output and stroke volume index were depressed after two days. The ATP content in the nonischemic region was lower than control, but recovered spontaneously toward the normal value within the first four days. Three metabolic and pharmacologic interventions known to affect cardiac adenine nucleotide metabolism were applied. Continuous i.v. administration of ribose which stimulates further adenine nucleotide biosynthesis attenuated the fall and promoted the restoration of ATP in the nonischemic myocardium within four days after coronary artery ligation. The elevation of LVEDP was attenuated with ribose after two and four days. The calcium antagonist gallopamil administered as i.v. infusion for two days led to a further reduction of all parameters of left heart function, but did not influence the increase in adenine nucleotide and protein synthesis that occurred in the nonischemic heart. Coenzyme Q10 had only slight effects on LVSP, LVEDP, and LV dP/dtmax, but attenuated significantly the fall in cardiac output and stroke volume index after two days following coronary artery ligation. Thus, all interventions affected differently the infarct-induced changes in heart and circulatory function. An improvement was observed with ribose and with coenzyme Q10.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504141     DOI: 10.1007/bf01907981

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  30 in total

1.  Left ventricular oxygen utilization in intact dogs: effect of systemic hemodynamic factors.

Authors:  W A NEILL; H J LEVINE; R J WAGMAN; R GORLIN
Journal:  Circ Res       Date:  1963-02       Impact factor: 17.367

2.  Studies on the first derivative of the ventricular pressure pulse in man.

Authors:  W L GLEASON; E BRAUNWALD
Journal:  J Clin Invest       Date:  1962-01       Impact factor: 14.808

3.  Some metabolic features of the development of experimentally induced cardiac hypertrophy.

Authors:  H G Zimmer; E Gerlach
Journal:  Eur Heart J       Date:  1982-04       Impact factor: 29.983

4.  Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium.

Authors:  W G Nayler; R Ferrari; A Williams
Journal:  Am J Cardiol       Date:  1980-08       Impact factor: 2.778

5.  Nifedipine reduces adenine nucleotide breakdown in ischemic rat heart.

Authors:  J W De Jong; E Harmsen; P P De Tombe; E Keijzer
Journal:  Eur J Pharmacol       Date:  1982-06-16       Impact factor: 4.432

6.  Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs.

Authors:  K A Reimer; J E Lowe; R B Jennings
Journal:  Circulation       Date:  1977-04       Impact factor: 29.690

7.  Timely administration of nisoldipine essential for prevention of myocardial ATP catabolism.

Authors:  J W De Jong
Journal:  Eur J Pharmacol       Date:  1985-11-26       Impact factor: 4.432

8.  Protection of ischaemic myocardium with coenzyme Q10.

Authors:  Y Nakamura; M Takahashi; J Hayashi; H Mori; S Ogawa; Y Tanabe; K Hara
Journal:  Cardiovasc Res       Date:  1982-03       Impact factor: 10.787

9.  Significance of the hexose monophosphate shunt in experimentally induced cardiac hypertrophy.

Authors:  H G Zimmer; H Ibel; E Gerlach
Journal:  Basic Res Cardiol       Date:  1980 Jan-Feb       Impact factor: 17.165

Review 10.  History of calcium antagonists.

Authors:  A Fleckenstein
Journal:  Circ Res       Date:  1983-02       Impact factor: 17.367

View more
  6 in total

Review 1.  Regulation of and intervention into the oxidative pentose phosphate pathway and adenine nucleotide metabolism in the heart.

Authors:  H G Zimmer
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

2.  The oxidative pentose phosphate pathway in the heart: regulation, physiological significance, and clinical implications.

Authors:  H G Zimmer
Journal:  Basic Res Cardiol       Date:  1992 Jul-Aug       Impact factor: 17.165

3.  Response of the rat heart to catecholamines and thyroid hormones.

Authors:  H G Zimmer; M Irlbeck; C K Kolbeck-Rühmkorff
Journal:  Mol Cell Biochem       Date:  1995 Jun 7-21       Impact factor: 3.396

4.  Ribose Supplementation Alone or with Elevated Creatine Does Not Preserve High Energy Nucleotides or Cardiac Function in the Failing Mouse Heart.

Authors:  Kiterie M E Faller; Debra J Medway; Dunja Aksentijevic; Liam Sebag-Montefiore; Jürgen E Schneider; Craig A Lygate; Stefan Neubauer
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

5.  Proof of concept and feasibility studies examining the influence of combination ribose, adenine and allopurinol treatment on stroke outcome in the rat.

Authors:  Kiterie M E Faller; Joshua Leach; Pamela Johnston; William M Holmes; I Mhairi Macrae; Bruno G Frenguelli
Journal:  Brain Neurosci Adv       Date:  2017-07-13

Review 6.  Potential Clinical Benefits of D-ribose in Ischemic Cardiovascular Disease.

Authors:  Linda M Shecterle; Kathleen R Terry; John A St Cyr
Journal:  Cureus       Date:  2018-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.